Co-designing Spanish videos to explain key pediatric cancer topics
Official title: Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
Run by University of Colorado, Denver · NCT07288476 · Data updated 2026-11-12
This project will test short Spanish-language educational videos co-created by parents, medical interpreters, and clinicians to help Spanish-speaking caregivers of children with cancer better understand important care topics.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | July 2, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT07288476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are legal caregivers aged 18 or older who are native or fluent Spanish speakers of a child/young adult (0–25 years) receiving cancer treatment (development phase) or caregivers of newly diagnosed or relapsed/refractory patients (≤1 month) who require an interpreter (pilot phase) and can provide consent and be available for study activities.
✕Probably not a fit
Caregivers who do not speak Spanish, who have sufficient English-language access to care without an interpreter, who have insufficient cognitive functioning to complete study activities, or whose child is not receiving cancer-directed therapy are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study partners Spanish-speaking caregivers, medical interpreters, and clinicians to co-design concise educational videos on high-yield pediatric oncology topics. In initial aims, participants collaborate to create and refine video content and format. In a pilot phase, the videos will be used with newly diagnosed or relapsed patients' caregivers who require interpreters to see if the materials improve caregiver knowledge and experience. Results will guide expansion to more languages and larger studies on the impact of multilingual educational videos.
Why it matters
Potential benefit: If successful, these videos could improve caregivers' understanding, reduce communication gaps, and make clinic interactions less stressful for Spanish-speaking families.
How similar studies have gone: Prior research suggests multilingual patient education can improve knowledge and satisfaction, but co-designed Spanish video interventions specifically for pediatric oncology are relatively novel and not widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Aims 1 and 2 (Video Development Phase): * Legal caregiver aged ≥18 years of a child/young adult (0-25 years) undergoing active cancer treatment in low-intensity phases or off therapy. * Native or fluent Spanish speaker. * Willing and able to provide verbal consent. * Willing to comply with study procedures and be available for the study duration. Aim 3 (Video Pilot Phase): * Legal caregiver aged ≥18 years of a child/young adult (0-25 years) with newly diagnosed or relapsed/refractory cancer (≤1 month).N * Native or fluent Spanish speaker. * Requires an interpreter for medical conversations. * Willing and able to provide verbal consent. * Willing to comply with study procedures and be available for the study duration. Exclusion Criteria: Aims 1 and 2: * Insufficient cognitive functioning to complete study procedures (as determined by PI). * Caregiver of a child/young adult who did not receive cancer-directed therapy. * Caregiver of a child/young adult receiving high-intensity cancer treatment. * Unable to read and speak Spanish fluently. Aim 3: * Insufficient cognitive functioning to complete study measures (as determined by PI).Caregiver of a child/young adult who did not receive cancer-directed therapy. * Caregiver of a child/young adult not receiving cancer-directed therapy. * Diagnosis of new or relapsed/refractory cancer occurred \>1 month prior to enrollment. * Unable to speak Spanish fluently. * Does not require an interpreter for medical conversations.
Where it's running
-
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Melanie Stall, MD
- Email: melanie.stall@childrenscolorado.org
- Phone: 720-777-1234
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.